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Purpose: There has been much discussion in the literature of factors that affect the 
mortality rate of patients who undergo repair of ruptured abdominal aortic aneurysms. 
Some studies have suggested restricting patient selection for repair on the basis of certain 
preoperative factors including age, increased creatinine level, low hemoglobin level, loss 
of consciousness, electrocardiographic changes, and preoperative cormorbid medical 
conditions. A retrospective r view of 96 patients who tmderwent repair of a ruptured 
abdominal aortic aneurysm was performed to determine whether these factors would 
necessarily be applicable to all populations. 
Methods: A retrospective chart review of all patients who underwent repair of a ruptured 
abdominal aortic aneurysm was performed over a study period of 20 years. Data was 
analyzed by both univariate and multivariate analysis. 
Results: The mean age of the patients was 73 years. The intraoperative mortality rate was 
23%. The in-hospital mortality rate was 60.4%, with a 30-day mortality rate of 56.3%. By 
univariate analysis of various factors associated with the mortality rate, hemoglobin level, 
creatinine level, lowest preoperative and average intraoperative systolic blood pressure, 
packed red blood cells transfused, estimated blood loss, intraoperative urine output, and 
temperature were statistically significant. A history of loss of consciousness was also 
statistically significant. No preoperative comorbid medical conditions were significant, 
nor was age. On a multivariate analysis, preoperative factors of loss of consciousness, a 
lowest preoperative systolic blood pressure less than 90 mm Hg, a hemoglobin level less 
than 10 g/dl, and a creatinine l vel greater than 1.5 mg/dl  were predictive of death. The 
effects of the hemoglobin level, creatinine l vel, and loss of consciousness onthe mortality 
rate were strongest in patients who had a lowest preoperative systolic blood pressure 
greater than 90 nun Hg. In patients who had the sets of preoperative factors that were 
associated with a 100% mortality rate, there were intraoperative factors that influenced 
their death. 
Conclusions: These findings suggest hat the factors (loss of consciousness, creatinine 
level, hemoglobin level) that are predictive of death may be a reflection of shock in this 
patient population. Further studies hould be directed to optimizing preoperative r sus- 
citation. Patients who have a ruptured abdominal aortic aneurysm should not be denied 
therapy on the basis of any specific set of preoperative factors. (J Vasc Surg 1997;26:939-48.) 
Ruptured abdominal aortic aneurysms (RAAAs) 
continue to be a significant cause of death in the 
United States. Mortality rates after repair of an 
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RAAA have not significantly changed in the literature 
in the past 20 years, still ranging between 30% and 
70% in the most recent reports. >23 The incidence of 
RAAA has not seemed to decrease with the increased 
number of elective repairs and may be increasing. 23,31 
Many different factors have been reported to be pre- 
dictive of death, including age, comorbid medical 
conditions, preoperative shock or hypotension, in- 
creased creatinine l vel, low hemoglobin/hematocrit 
level, technical complications, and postoperative 
complications. 1-3° With the continued emphasis on 
cost-containment, there have been increasing discus- 
sions as to the possibility of withholding repair from 
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Table I. Comparison of mortality data and 
significance before and after 1985 
Total Mortality Age 
Year Alive Dead patients rate (yr) 
Before 1985 11 28 39 71.8% 70.7 
After 1985 27 30 57 52.6% 73.7 
Comparison yielded the following results: p = 0.046; odds ratio, 
2.29; confidence interval, -0.008 to 0.391. 
some patients if their death was 100% predictable 
based on a specific constellation ofpreoperative fac- 
tors. 4'5'7'10'14'19 This study was undertaken to deter- 
mine whether certain preoperative patient-related 
variables were able to predict death in our patient 
population. 
METHODS 
One hundred twenty-two patients were admitted 
to the Long Island Jewish Medical Center with the 
diagnosis of RAAA in the period between January 
1976 and July 1996, as identified by ICD-9 code. 
Twenty-six of these patients were eliminated from 
the study for the following reasons: 13 patients had 
nonruptured abdominal aortic aneurysms (AAA), 
nine patients had thoracoabdominal aneurysms, two 
patients had aortoduodenal fistulas (one with a pre- 
vious AAA repair), one patient had an infected pseu- 
doaneurysm from a previous AAA repair, and one 
patient had an aortocaval fistula. The remaining 96 
patients had RAAAs and all underwent attempted 
repair. Data was collected for various preoperative 
and intraoperative ariables. Preoperative variables 
included coexisting medical conditions, electrocar- 
diographic hanges, age, creatinine l vel, hemoglo- 
bin level, a history of loss of consciousness (LOC), 
and lowest recorded preoperative systolic blood pres- 
sure (aSBP). Intraoperative ariables included aver- 
age intraoperative systolic blood pressure (iSBP), 
temperature at the end of the procedure, intraopera- 
rive urine output, estimated blood loss, and transfu- 
sion requirements (packed red blood cells). Before 
1985, 14 general and vascular surgeons performed 
these surgeries. After 1985 six vascular surgeons per- 
formed the majority of the surgeries; four of the 
RAAAs were repaired by an additional four different 
vascular surgeons. Univariate analysis was performed 
using X 2 or Fischer's exact est for categorical data 
and the t test for the numerical data with the In Stat 
program (GraphPad Software, version 1.11a) for the 
personal computer. Multivariate statistical tech- 
niques (including stepwise linear regression and for- 
ward and backward logistic regression) were per- 
Table II. Incidence and significance of 
comorbid medical conditions 
Alive Dead 
Comorbid conditions (% of total) (% of total) p 
Diabetes mellitus 5 (13.2) 2 (3.4) 0.084 
Chronic obstructive lung disease 8 (21.1) 15 (25.9) 0.254 
Chronic renal failure/insufficiency 6 (15.9) 15 (25.9) 0.186 
Coronary artery disease 19 (50) 27 (46.6) 0.871 
Hypertension 13 (34.2) 24 (41.4) 0.313 
Congestive heart failure 1 (2.6) 1 (1.7) 0.638 
Smoking 17 (44.7) 21 (36.2) 0.266 
Total patients 38 58 
formed using the SPSS 6.1 package for Windows 3.1 
to determine whether a combination of variables 
would be predictive of death. 
RESULTS 
There were 77 men and 19 women. The intraop- 
erative mortality rate was 23% (22 of 96 patients), 
and death was the result of continued hemorrhage 
and irreversible shock in the majority of cases. The 
30-day mortality rate was 56.3% (54 of 96 patients), 
but the mortality rate at discharge was 60.4% (58 of 
96 patients). Of these patients, 37 deaths (63.7%) 
occurred within the first 48 hours. The four deaths 
after 30 days occurred on hospital days 48, 72, 83, 
and 92. These patients died after having a do-not- 
resuscitate order initiated by the patient or family in 
patients who had a prolonged and complicated post- 
operative course. Our previous report 2that the mor- 
tality rate decreases when repair of RAAAs is limited 
to vascular surgeons remains true (Table I); this 
occurred in 1985. The mean age of the patients 
increased after 1985, which was statistically signifi- 
cant (p = 0.05). No other time period had statistical 
significance compared with one another, even when 
considering the introduction of the cell saver in 
1991. 
The preoperative comorbid medical conditions at 
presentation were not significantly different between 
survivors and nonsurvivors (Table II). The mortality 
data at discharge that were associated with factors 
that were considered significant in previous tudies 
are listed in Table III. The preoperative factors that 
were significantly correlated with death were LOC, 
aSBP less than 90 mm Hg~ creatinine level at or 
greater than 2 mg/dl, and hemoglobin at levels less 
than 10 g/dl (Tables IV and V). The other variables 
studied were not significantly different, including age 
and presence of electrocardiographic c anges. Of the 
intraoperative ariables tudied, an iSBP less than 90 
mm Hg, packed red blood cells transfused, estimated 
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Table II I .  Mortality risk associated with 
variables found to be significant in previous 
reports of RAAA 
Mortality 
Alive Dead Total rate (%) 
Hemoglobin (g/dl)  
<9 2 7 9 77 
9 to 10 5 18 23 78.2 
11 to 12 9 10 21 47.6 
>13 19 l I  l l  36.6 
Unknown 1 12 13 92 
Age (yr) 
<70 15 23 38 57.9 
70 to 80 15 24 39 61.5 
>80 8 11 19 57.9 
Creatinine (mg/d l )  
>1.5 20 16 36 44.4 
1.5 to 1.9 10 10 20 50 
>2 2 13 15 86 
Unknown 6 19 25 76 
Temperature 
<91 ° F 1 10 11 90.9 
91 ° to 96 ° F 23 25 48 52 
>96 ° F 8 4 12 33 
Unknown 6 19 25 76 
pRBC (units) 
<5 15 9 24 37.5 
5 to 10 15 22 37 59.2 
>10 8 27 35 77.1 
EBL (L) 
<4 22 18 40 45 
4 to 7 11 13 24 54.2 
>7 3 10 13 76.9 
Unknown 2 17 19 89.5 
Urine output (ml) 
<200 2 11 13 84.6 
200 to 800 13 15 28 53.6 
>800 13 15 28 53.6 
Unknown 8 23 31 74.2 
aSBP (mm Hg) 
<90 6 31 37 83.8 
>90 32 27 59 45.8 
iSPB (mm Hg) 
<90 14 48 62 77.4 
>90 24 10 34 29.4 
LOC 
Present 8 26 34 76.5 
Absent 30 32 62 51.6 
pRBC, Packed red blood cells; EBL, estimated blood loss. 
blood loss, urine output, and temperature showed 
significance by univariate analysis (Table IV and V). 
Twenty-one patients (21.9%) had an intraoperative 
arrest, and all died within 15 days of surgery. Nine of 
these 21 died in the operating room. Conversely, of 
the patients who had a preoperative arrest (n = 9), 
three left the hospital alive and are still alive at 41 
months, 10 months, and 2 months after the opera- 
tion. 
On mul t ivar ia te  ana lys i s ,  no  group  o f  p reopera -  
t ive  comorb id  med ica l  cond i t ions  had  a pred ic t ive  
probab i l i ty  o f  more  than  0 .69 .  Age  remained  ins ig -  
Table IV. Univariate analysis of factors 
associated with mortality rate of RAA 
S~rpivors Nonsurvivors 
Variable (mean) (mean) p 
Hemoglobin (g/di)  12.8 11.2 0.002 
Creatinine (mg/di )  1.32 1.76 0.002 
aSBP (mm Hg) 110.7 89.2 0.001 
iSBP (mm Hg) 92.6 48.5 <0.001 
pRBC (units) 7.2 11.7 0.001 
EBL (L) 3.21 5.45 0.004 
Urine output (ml) 942 625 0.05 
pRBC, Packed red blood cells; EBL, estimated blood loss. 
Table V. Univariate analysis of 
significant variables 
Variant p OR CI (95%) 
ECG changes 0.33 - -  - -  
LOC 0.014 3.047 0.09 to 0.05 
Hemoglobin < 10 g/dl  0.01 3.8 0.05 to 0.5 
Hemoglobin < 9 g/d l  0.19 - -  - -  
Creafinine > 1.5 mg/d l  0.06 0.417 -0 .01  to 0.44 
Creafinine > 1.9 mg/d l  0.09 - -  - -  
Creafinine > 2 mg/d l  0.04 7.052 - -  
SBP < 90 mm Hg 0.0002 6.124 0.17 to 0.58 
iSBP < 90 mm Hg <0.0001 8.289 0.28 to 0.68 
Age > 70 yr 0.5 - -  - -  
Age > 80 yr 0.53 - -  - -  
EBL > 6 L 0.04 0.347 -0 .0002 to 0.50 
pRBC > 7 units 0.013 2.822 0.048 to 0.443 
Urine output < 200 ml 0.037 0.21 
Temperature < 93 ° F 0.017 0.32 0.045 to 0.506 
OR, Odds ratio; CI, confidence interval; ECG, electrocardio- 
graphic; EBL, estimated blood loss; pRBC, packed red blood cells. 
nificant. A combination of an aSBP and an iSBP less 
than 90 mm Hg had a mortality risk of 86.7% (26 of 
30 patients) and a predictive probability of 0.89, 
which was highly significant (p < 0.00001; odds 
ratio, 35.1). This group represented 44.8% of in- 
hospital deaths. In fact, preoperative arrest or hypo- 
tension followed by an intraoperative arrest had a 
100% mortality risk (11 of 11 patients); all deaths 
occurred within 4 days of surgery. Of all in-hospital 
deaths, 91.4% (53 of 58 patients) had either an aSBP 
less than 90 mm Hg, an iSBP less than 90 mm Hg, or 
a combination of both. Five patients died who were 
never hypotensive and had no other preoperative 
factors that could predict their death. There were 
four patients who survived espite having both aSBP 
and iSBP less than 90 mm Hg. Two of these patients 
had creatinine levels of 2 mg/dl ,  one was 81 years 
old, and three had LOC. Two of the four patients 
had both LOC and a creatinine level of 2.0 mg/dl .  
A creatinine level greater than 1.5 mg/d l ,  a 
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Fig. 1. Mortality rate as related to the number of factors present and preoperative hypoten- 
sion. Factors considered are LOC, hemoglobin level less than 10 g/dl, and creatinine level 
greater than 1.5 mg/dl. 
Table VI. Multivariate analysis of 
preoperative factors that affect mortality rate 
Mortality 
rate (%) p Odds ratio 
All patients (n = 96) 
< 2 factors (n = 72) 




aSBP < 90 mm Hg (n = 37) 
< 2 factors (n = 21) 




aSBP > 90 mm Hg (n = 590) 
< 2 factors (n = 51) 




hemoglobin level less than 10 g/d l ,  and LOC were 
also found on multivariate analysis to predict 
death. Fig. 1 demonstrates an increasing mortality 
rate as the number of  these three factors present 
increased from one to three. The mortality rate 
increased greatly when there were two or more of  
these factors present (Table VI). However, as can 
be seen in both Fig. 1 and Table VI, the effect of 
these factors was only significant if the aSBP was 
greater than 90 mm Hg. Mortality data for pa- 
tients with either LOC, a creatinine level greater 
than 1.5 mg/d l ,  or a hemoglobin level less than 10 
g /d l  or a combination of these factors are shown 
in Table VII. There are three sets of  factors that 
had a 100% mortality risk (Table VII). However, 
on further analysis of  the patients with these 
groups of  factors, other reasons may have contrib- 
uted to their deaths. One of  the patients who had 
all three factors and an aSBP greater than 90 mm 
Hg had an intraoperative arrest, and the other was 
hypotensive during the operation, with an average 
iSBP of 70 mm Hg. Two of  the five patients who 
had LOC and hemoglobin level less than 10 g /d l  
had intraoperative arrests, three had iSBP less than 
or equal to 70 mm Hg, and all had an aSBP less 
than 90 mm Hg. Two of  the three patients who 
had LOC, a creatinine level greater than 1.5 mg/  
dl, and an aSBP greater than 90 mm Hg had iSBP 
less than 80 turn Hg. The last patient lived 72 days 
after repair and died after a do-not-resuscitate or-
der had been initiated. His prolonged course was 
related to renal failure that ultimately required 
dialysis and nosocomial pneumonia. 
D ISCUSSION 
An RAAA remains a highly fatal event despite 
improvements in perioperative care over the past 10 
years, with reported mortality rates of 23% to 70%. 
Our group, in addition to several others, have noted 
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Table VII. Mortality rate of predictive preoperative factors alone and in combination 
Al l  patien~s aSBP < 90 mm Hg aSBP > 90 mm Hg 
Preoperative factors (n = 96) (n = 37) (n = 59) 
LOC present 76.5% (n = 34) 82.6% (n = 23) 63.6% (n = 11) 
Creafinine > 1.5 mg/d l  63.6% (n = 31) 81.8% (n = 12) 57.9% (n = 19) 
Hemoglobin < 10 g /d l  68.4% (n = 19) 81.8% (n = 11) 57.9% (n = 8) 
Hemoglobin < 10 + creatinine > 1.5 50% (n = 4) 50% (n = 2) 50% (n = 2) 
Hemoglobin < 10 + LOC 100% (n = 5) 100% (n = 5) 0% (n = 0) 
Creatinine > 1.5 + LOC 50% (n = 6) 66.6% (n = 3) 100% (n = 3) 
LOC + creatinine > 1.5 80% (n = 5) 66.6% (n = 3) 100% (n = 2) 
+ hemoglobin < 10 
some improvement in the survival rate when compar- 
ing different decades; however, the mortality rates 
remain h igh .  9'12'3"7'27'28 Because of the high cost of 
care of patients who have RAAs  (around $30,000 
to $50,000 per patient), several recent reports have 
suggested that certain preoperative variables might 
be used to select he patients who are most likely to 
die and thus would be best treated without opera- 
tion. 4,14,19 This approach may have some appeal in 
this age of "cost-effective" therapy, but could have 
significant moral, ethical, and legal implications. 
Denying a potentially life-saving procedure on 
the basis of predictive factors may not apply to all 
populations. This study was undertaken to see 
whether the factors that were suggested in the 
reports of Johansen et al. 4 and more recently by 
Hardman et al. 19 could be applied more univer- 
sally. Both studies uggested that older age (great- 
er than 80 years and greater than 76 years, respec- 
tively) was predictive of a high risk of mortality. 
Our results showed no significant difference in 
mortality rates in the various age groups, nor was 
there a difference in the age of patients who had 
other factors associated with an increased mortality 
rate (e.g., creatinine level greater than 1.5 mg/d l ,  
creatinine level greater than 2 mg/d l ,  hemoglobin 
level less than 9 g/dl ,  hemoglobin level less than 
10 g/dl ,  aSBP less than 90 mm Hg, iSBP less than 
90 mm Hg) when compared with patients who did 
not have these factors present. In fact, despite the 
increased age of our patient population after 1985, 
the mortality rate improved. The lack of signifi- 
cance of age on the mortality rate has been found 
by several other groups. 1'2'6'8'9'16-18'21'24'28'29 
In this study there was a trend for an increased 
mortality rate with increasing creatinine level, but 
this was only significant at levels greater than 2 mg/  
dl. A hemoglobin level less than 10 g/dl  proved 
statistically significant on univariate analysis. How- 
ever, 21 of 23 patients who had this factor had either 
a low aSBP or an iSBP less than 90 mm Hg, and nine 
had both. Multivariate analysis also revealed that a 
combination of two or more of the preoperative 
factors of a history of LOC, a hemoglobin level less 
than 10 g/dl ,  and a creatinine level greater than 1.5 
mg/dl  was predictive of death, most strongly in 
those patients whose lowest preoperative blood pres- 
sure was greater than 90 mm Hg. This fact, in com- 
bination with the intraoperative ariables that were 
present in this group of patients, makes it difficult o 
definitely separate the effect of a shock state on mor- 
tality risk from that of the above factors. In fact, our 
data suggest that patients who have factors that 
could reflect significant hemorrhagic shock (low pre- 
operative blood pressure, low hemoglobin level, 
LOC, and an increased creatinine l vel) and continue 
to show signs of an unresolving shock state in the 
operating room (low iSBP, high transfusion require- 
ments, high estimated blood loss, low urine output, 
and low temperature at the end of the procedure) 
were most predictive of death. In particular, the 
combination of lowest aSBP and an iSBP less than 90 
mm Hg had the highest predictive power. 
It has been reported that the cost of repair in a 
patient with an RAAA is around $40,000 per patient, 
with a range of $4473 to $284,374, with an addi- 
tional cost of $3953 to $10,557 per added life-year, 
depending on the patient's age. 4,13,31-3a As Seiwart et 
al. 32 pointed out, this is not that expensive when one 
considers that hemodialysis costs between $35,000 
and $50,000 per year, which is accepted by national 
standards as a reasonable xpenditure. In addition, 
although results have varied in different reports, the 
majority found that the late survival rate of patients 
after repair of an RAAA, once discharged from the 
hospital, is not significantly different from that of 
patients who undergo elective repair36,2a,a4 36The 
findings reported in this study suggest hat efforts 
would be better directed to improving the methods 
used to resuscitate patients before operation, as well 
as having a specialized team. This concept is sup- 
ported by several groups .  9A7,2s,27,28 The high mortal- 
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ity rate reported by Johansen et al. 4 might be a result 
of an inadequate preoperative r suscitation period, as 
the average time to operation was 12 minutes and it 
is not clear that the time to the operating room was 
related to the patient's being in extremis or their 
policy of expedient surgery. Several studies have 
shown that preoperative hypotension is predictive of 
death, and several have shown that a longer period of 
preoperative r suscitation was correlated with a bet- 
ter survival rate up to a certain point. 12,21,2'4,28 The 
previous tudy from our group showed that the mor- 
tality rate actually decreased for patients who did not 
undergo operation immediately and who were de- 
layed for as long as 4 hours, after which the mortality 
rate began to increase. 2 It is difficult o sort out from 
retrospectively collected ata whether these patients 
were more likely to survive with longer preoperative 
resuscitation because they had contained ruptures 
and could be resuscitated, or whether their survival 
rate was better because time was taken to resuscitate 
them. There has been some suggestion i the trauma 
literature that over-resuscitation may lead to an in- 
creased mortality rate.4°,41 However, as others have 
pointed out, they do not address the effect of gentle 
resuscitation, 42 and at least one other animal study 
suggests that judicious resuscitation is beneficial and 
that no resuscitation had the highest mortality rate. 4s 
In addition, at least two reports addressing RAAAs 
suggest that preclamp resuscitation may be of benefit 
to improve survival rates. 22,28 It is difficult to deter- 
mine from existing reports how much or how long 
this resuscitation should be before malting the inci- 
sion. 
CONCLUSION 
Although several factors in combination and in- 
dependently predict death in our report, they may 
actually be  a reflection of shock, even in patients 
whose preoperative blood pressure isrelatively stable. 
As seen with other causes of hemorrhagic shock, 
blood pressure does not adequately predict the de- 
gree of organ perfusion. Perhaps these factors would 
be better used to predict he need for resuscitation i  
stable patients rather than selecting those from 
whom to withhold therapy. This approach may not 
i 
only reduce mortality rates but might also reduce 
cost by reducing complications a sociated with shock 
(e.g., ischemic bowel). Therefore, a better method 
for improving the cost-effectiveness of RAAA repair 
might be to determine which patients would most 
benefit from preoperative resuscitation, how much 
resuscitation is of benefit, and the maximum time 
that it is of benefit. Although three different combi- 
nations of factors had a 100% mortality risk (Table 
VII), the number of patients who have these factors 
is small, and intraoperative factors like blood pressure 
may influence the mortality rate. We do not believe 
that the data are strong enough at this point to deny 
repair to any patient with a RAAA on the basis of a 
specific set of preoperative factors. In addition, even 
though our data demonstrated a 100% mortality rate 
for patients who had an arrest during the operation, 
we do not believe that efforts hould cease at the time 
of an intraoperative arrest, as other groups have had 
survivors. 6,7 However, like any other surgical ther- 
apy, each patient's care must be based on the clinical 
picture and on the patient's and the family's wishes. 
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D ISCUSSION 
Dr. Michael F. Silane (New York, N.Y.). I would like 
to congratulate the authors on a thoughtful analysis of a 
complex problem. I think the paper addresses several very 
important issues. As many in the audience are probably 
familiar, over the past 3 to 5 years there have been a 
number of papers that suggested that maybe, on the basis 
of preoperative factors, we should not be operating on 
some of these ruptured aneurysms. Some of these data 
were presented at the SVS/ISCVS meeting about 6 years 
ago. Dr. Stanley Crawford, who I hope everybody in the 
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audience here is still familiar with, strongly disagreed with 
the assumption that we should be denying treatment to 
some of these patients. I think this paper counterbalances 
those papers in the literature that suggest a nonoperative 
approach. This paper looks at many of the same preopera- 
tive variables and factors and comes to an opposite conclu- 
sion. In particular, the patients who had a preoperative 
cardiac arrest, which we would think would be the worst 
predictor in the preoperative setting, had a 33% survival 
rate. So even in those patients, and in manyy others of their 
critically ill patients, they were able to have a substantial 
salvage rate. So I think that we really should not be de W- 
ing treatment to patients no matter how critically ill they 
might be. 
The second thing that was alluded to in the paper is 
that in this current setting of cost-containment and being 
efficient about use of our resources, I think we're going to 
have more and more pressure on us to possibly limit our 
treatments to those patients in whom we're going to be 
most effective. And in patients like this we may be some day 
faced with the threat hat we should not be operating on 
these patients, and it's papers like this that are going to 
support he fact that many of these patients can survive and 
that we should be treating them. 
I think there is another eason for operating on these 
deathly ill patients. Besides the fact that some of the pa- 
tients will survive, I think, especially in the setting of 
teaching institutions, that we really hone our management 
skills and our operative skills not by operating on just the 
easiest cases, but by taking on these terrific challenges of 
critically ill patients. That's when we really develop our 
skills, and I think we become better prepared to take care 
of the less-sick patients. 
I want to make one point that's a factor that I think 
is critical in the management of these ruptured aneu- 
rysms, and I make this point all the time with the 
residents. It may be fairly obvious when I first say it, but 
despite that I 've been to too many morbidity and mor- 
tality conferences and heard this presented too often, 
one of the main factors in determining whether a patient 
makes it through the operation is the avoidance of an 
intraoperative misadventure. Now that seems very obvi- 
ous, but I 've seen all too often in the surgical team's zeal 
to get in there quickly and to get control immediately, 
they get into what I call the "venous frame" around the 
aneurysm, that is the vena cava on one side, the renal 
vein superiorly, the inferior mesenteric vein, and the iliac 
veins. Particularly the renal vein and the inferior mesen- 
teric vein, with the surgeon in a rush to get control at 
the neck of the aneurysm, are prone to injury, and if this 
happens then the roof caves in. If  you've been able to get 
to the operating room with the patient alive, usually 3 or 
4 more minutes is not going to make much difference. I 
think it behooves us to not be so vigorous and to be a 
little more careful, because I've seen too many cases 
where these structures have been entered when they 
could have been avoided, and that was really the thing 
that caused the demise of the patient rather than the 
rupture of the aneurysm. 
I have one question, which is really divided into two 
parts. Based on the data that you've presented, and in 
particular I 'm thinking about the fact that there was a 
100% mortality rate in the 15 patients who had an intraop- 
erative arrest, would you, at this point, in your next patient 
who has an intraoperative arrest, not resuscitate or at least 
cut back on treatment realizing that we're predicting a bad 
result no matter what we do? 
The corollary would be what if over the next few years 
we determine that a certain group of factors has a 15% or a 
10% or a 5% chance of success of survival, would you not 
operate on that patient just because the predicted results 
are not good? 
Dr. Vivienne J. Halpern.  I would like to thank Dr. 
Silane for his comments. In terms of not treating patients 
who have intraoperative arrests, when we looked back at 
those patients there were many venous injuries, which as 
you suggested can lead to a significant mortality rate. The 
patients who had venous injuries had significant blood loss, 
which led to their cardiac arrests. So I think that the answer 
is to avoid events that lead to an intraoperative arrest. 
However, if the patient hen has an arrest during the 
operation, I think that I would at least ell the family, if the 
patient made it out of the operating room, that the patient 
had a very low likelihood of survival and that aggressive 
therapy probably would not be of any benefit. In terms of 
the second part of the question, if a patient had a 5% or 
i0% chance of survival, I think that gets into ethical issues. 
If it was my mother or father, I would want to give them 
that 5% or 10% chance because, as our long-term data and 
those of others suggest, if you survive a rupture, you have a 
good chance of living a long time afterwards. 
Dr. Ibrah im M. Ibrah im (Englewood, N.I.). Having 
had the misfortune of being involved with just about every 
ruptured aneurysm at Englewood for more than 15 years, I
made a couple of observations that confirm what is already 
published in the literature. One of them is the timing. 
Have you looked at the time of the onset of symptoms and 
the time of the patient arriving in the emergency depart- 
ment to the time of surgery, and has that had any bearing 
on the results? We found that this was important. We really 
educated our emergency medical services taff and emer- 
gency department staff to the point where the pump is 
primed very early in the course of the patient's problem 
and we get these patients to the operating room very early. 
The other question I have is about hypotension. I 'm a 
little confused about what you're talking about as far as 
hypotension is concerned. My personal observation has 
been that there was no correlation between the degree of 
hypotension and the degree of the hematoma or blood 
loss. As a matter of fact, when these patients arrive at the 
emergency department hypotensive, the one thing I insist 
on is that nobody tries to raise their blood pressure. The 
tendency is to immediately give them either vasopressors 
or pour fluids and what have you to raise their blood 
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pressure. I believe that that is a dangerous thing to do. The 
only time we allow the anesthesiologist to raise the blood 
pressure is after the aorta is cross-clamped. I wonder 
whether you could address that. 
Dr. Halpern. In terms of looking at the time of onset 
of symptoms to the emergency department, our charts 
were not consistently documented enough to make any 
comments on that. In terms of looking at the time from the 
emergency department to the operating room, although 
the initial analysis from our institution in 1991 showed a 
higher mortality rate with a time greater than 6 hours, on 
analysis now the time was not significantly different be- 
tween survivors and nonsurvivors. 
However, it is interesting that our data showed from 0 
to 3 hours from the emergency department to the operat- 
ing room, the mortality rate actually decreased with increas- 
ing time. It was only after 3 hours that the mortality rate 
increased. There are a few other papers that have similar 
findings, namely, that for the first hour or two, the more 
time you are in the emergency room, the lower the mortal- 
ity rate. It is not clear from any of these papers or from our 
data whether this has to do with the fact that these patients 
are being resuscitated or the fact that they have contained 
ruptures and therefore can make it to the operating room 
in that time period. 
There was no direct correlation between hypotension 
and whether the rupture was contained or not. It was the 
hypotension itself that correlated with mortality. Our feel- 
ing on the hypotension issue and how much or whether 
you resuscitate is that it may end up being something like a 
trauma patient. After all, it's sort of like having a gunshot 
wound to the aorta. The trauma data have gone back and 
forth in terms of resuscitation. Originally, all patients were 
vigorously resuscitated. Then there was a group that was 
performing hypotensive resuscitation, ot getting the 
blood pressure above 80 mm Hg systolic. Now the data 
have shifted back to resuscitating but not to drive the 
blood pressure above 90 to 100 mm Hg. 
Now, the corollary of this is that if you are resuscitating 
a trauma patient who is not responding appropriately to
fluid or becomes hypotensive again after the second liter, 
the patient belongs in the operating room. So I think one 
thing that we need to look at in patients with a ruptured 
aneurysm is how much resuscitation and where should it 
be done. Obviously, these patients need to be in the oper- 
ating room to control the source of bleeding. Perhaps we 
should be resuscitating them on the table before incision to 
try and get them out of shock before induction. Or perhaps 
it should be done with the clamp in position around the 
aorta and ready to go. It has been shown again in the 
trauma data that the faster you get these patients out of 
shock, the better they do. 
Dr. Dominic A. DeLaurentis (Philadelphia, Pa.). I 
enjoyed this paper immensely, and I'm very happy that you 
found no factors that would eliminate any patient from 
having a chance to survive. I think that the cost-contain- 
ment issue, if we go that direction, would put us back 
about 40 years, when we used to open up these patients, 
make the diagnosis, and close them because there was 
nothing else to do. I think when the cost-containment 
issues do come up that our counterattack should be that if 
we repair these aneurysms when they're small, they would 
not rupture. That's the argument I've always used when 
people try to convince me otherwise. 
I want to point out a few things, because this has long 
been a fascinating subject o me. If you insert the word 
"patient" in front of your title and say "patient factors" 
rather than just "factors" that it would more closely define 
exactly what you did in your paper. There are many other 
factors that are not patient-related. For example, there 
were 96 patients over a 20-year period; that comes out to 
about four or five patients a year. One of the problems with 
ruptured aneurysms i  that if we would get one a day, we 
would become quite proficient. The results would be bet- 
ter. But we don't. And so one of the other factors I 'm 
talking about is how many surgeons--perhaps you can 
briefly comment on this--how many surgeons were in- 
volved in these 96 patients? How many different anesthesi- 
ologists were involved? How well were they trained? How 
well did they understand this procedure? Did you have the 
same nurses? What time of the day? In other words, I 'm 
convinced that a patient who undergoes the operation at 
two in the afternoon, or one in the afternoon, is a lot better 
off than someone who undergoes the operation at one in 
the morning. Were there platelets available or not avail- 
able? Did you reclaim blood? In summary, ou looked at 
the patient factors, and I think now you have to look at all 
the other factors to give you that broad picture. But I 
enjoyed the paper, and I 'm very happy that we're not 
taking a step backward. 
Dr. Halpern. In terms of the number of surgeons, 
actually, as seen from the paper originally from our institu- 
tions, there was a difference in the mortality rate after a 
policy was instituted that only vascular surgeons would do 
this procedure. Before 1985 there were 11 vascular and 
general surgeons performing the procedure, and after that 
there were six vascular surgeons performing the procedure. 
There is still a difference in the mortality rate that is statis- 
tically different. 
In terms of the anesthesiologists, i 'scome who may. 
We have absolutely no control over that. And it is very hard 
to sort out from the data because there are just too many 
people involved. I can tell you from my limited experience, 
I've done four ruptures myself, that I was lucky to have the 
anesthesiologists who are involved in most of our vascular 
cases, and they are much more aware of the need to 
resuscitate these patients aggressively in the operating 
room, replace their platelets, give them fresh frozen 
plasma, and all those other things that you mentioned. 
In terms of recycling the blood with the Cell Saver, 
there was no difference in the mortality rate before and 
after Cell Saver was instituted, so I 'm not sure it's as much 
that as malting sure the patient's volume is appropriately 
replaced. 
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Dr. Enrico Ascher (Brooklyn, N.Y.). Dr. Halpern, 
you said that you would consider saving your father and 
your mother at a 5% or 10% chance of survival. How about 
your grandfather and your grandmother? What if they are 
90 years old, they arrest in the emergency room, and now 
they're intubated with a pressure of 60 mm Hg, would you 
still take them to the operating room and try to resuscitate 
them or not? 
Dr. Halpern. To be honest, it would depend on what 
their life was like before. In other words, if my 90-year-old 
grandmother was senile, had many medical problems, and 
was probably going to die within the year anyway, then no, 
I don't think I would be so aggressive in taking here to the 
operating room. On the other hand, at least one of our 
patients was a 90-year-old who jogged 4 miles a day, and 
that person should be undergo the operation and be given 
the chance of survival. 
Dr. Ascher. I agree 100%. Now, there is a little bit of 
controversy about the approach, the control of the aorta 
on ruptured aneurysms, between supraceliac versus direct 
infrarenal clamping. In your review of your cases, did you 
find any difference? Do you advocate any approach in 
addition? Is there any disadvantage to it? 
Dr. Halpern. The recording of what patients had 
suprarenal c amps as opposed to just infrarenal clamps was 
inconsistent. Our general policy is that we place a clamp in 
the suprarenal position. We don't necessarily close the 
clamp, we just place it there. We then go for the infrarenal 
aorta. I f  for some reason there is difficulty getting control 
of the infrarenal aorta and the patient is hypotensive, we 
then close the supraceliac lamp while we get out the 
infrarenal aortic neck. 
Dr. Ascher. I 'm also sure that those surviving patients 
gave you some trouble in the postoperative p riod. In our 
own experience, 70% of the patients who survived had 
major complications, with a cost of approximately 
$145,000 for the hospital. Actually, my administrator is 
very happy when I operate on a patient and the patient dies 
the next day- i t ' s  the only way they can make some 
money. Have you noticed that the complication rate of the 
surviving patients is very high, and that it is a costly proce- 
dure? 
Dr. Halpern. We did not look at cost. There are 
several papers out that looked at cost. And, as you found, 
the patients who died in the first 24 or 48 hours cost the 
hospital east. The average cost seen in the literature is 
between $20,000 and $40,000 or $50,000 per hospital 
stay. 
However, there are some papers that have looked at 
this issue in terms of survival and quality of life. They found 
that if you survived a rupture, once you get out of the 
hospital your survival rate is no different han that of age- 
and sex-matched controls. They also felt that the cost is 
really not that much if you consider that the cost of hemo- 
dialysis for a patient every year costs $30,000 to $50,000. 
Dr. Kumar tL Patel (Glen Ridge, N.J.). Along the 
same train of thought hat we were just discussing about 
patient factors, some years ago we had occasion to review 
the literature on ruptured aneurysms rather extensively, 
and a few things were very striking at that time. It was quite 
amazing that most series reported only patients who un- 
derwent the operation. Accordingly, all of the patients who 
did not undergo the operation were never even brought 
into the equation, and obviously that's a false calculation of 
what the results are. 
But what I wanted to ask you, really, is that apart from 
patient factors there are pathologic factors; for example, a
free rupture is a totally different situation from a contained 
rupture, and so is rupture into the vena cava or duodenum. 
There has been a tendency to classify all of these aneurysms 
together. In your review of the literature, did you find that 
striking? Would you give us your opinion on that, please? 
Dr. I-Ialpern. When we looked at our data, we ex- 
cluded anybody who had anything other than a straightfor- 
ward ruptured infrarenal AAA. In other words, we ex- 
cluded the aortoduodenal fistulas, aortocaval fistulas, iliac 
artery aneurysms, and other complex cases. 
Whether a patient had a free rupture versus contained 
rupture did not seem to be reliably recorded. For instance, 
I know from when I was the fellow at Long Island Jewish 
that there were at least three cases that were free ruptures 
that were not recorded that way. So I decided not to use 
those data because it might not be accurate. 
Dr. Patel. It seems amazing to do that, because it 
totally distorts the results. 
Dr. Halpern. Right. In terms of the literature, you are 
right that there are a lot of papers that combine all types of 
ruptured aneurysms. If fact, one of the papers I reviewed 
that concluded that perhaps repair should be denied to 
certain patients included ruptured thoracoabdominal an- 
eurysms, which is obviously a very different entity. They 
also had several common iliac artery aneurysm ruptures. I 
think that it is obvious that these aneurysms and aortoduo- 
denal and aortocaval fistulas are clearly different entities, 
and I think they have to be dealt with differently. 
